MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trialSepideh Saadatmand, Edith van Druten, Marc B. I. Lobbes et al.|The Lancet Oncology|2019Cited by 174
Survival benefit in women with <i>BRCA1</i> mutation or familial risk in the <scp>MRI</scp> screening study (<scp>MRISC</scp>)Sepideh Saadatmand, Madeleine M.A. Tilanus‐Linthorst, Inge‐Marie Obdeijn et al.|International Journal of Cancer|2015Cited by 97
Cost-Effectiveness of Screening Women With Familial Risk for Breast Cancer With Magnetic Resonance ImagingSepideh Saadatmand, Harry J. de Koning, Madeleine M.A. Tilanus‐Linthorst et al.|JNCI Journal of the National Cancer Institute|2013Cited by 65
Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial RiskH. Amarens Geuzinge, Inge-Marie Obdeijn, Emiel J. Rutgers et al.|JAMA Oncology|2020Cited by 53